Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.41 -0.74 (-2.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. ↗

February 20, 2025

Via The Motley Fool

Moderna: A Generational Opportunity for Investors in 2025

February 19, 2025

Moderna had a weak quarter but reaffirmed guidance, expecting three new product approvals in 2025 and as many as ten more within three years.

Via MarketBeat

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 18, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares? ↗

February 14, 2025

The company came up with a mixed fourth-quarter report, but kept its outlook for 2025.

Via Investor's Business Daily

Why Moderna (MRNA) Stock Is Up Today

February 18, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 financial results....

Via StockStory

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday ↗

February 18, 2025

Via Benzinga

Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges ↗

February 18, 2025

Moderna misses Q4 EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

February 18, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

February 18, 2025

Via Benzinga

Health Insurance ETFs in Focus as RFK Jr Takes Over HHS ↗

February 17, 2025

Robert F. Kennedy Jr. has taken office as HHS secretary, which could impact the healthcare sector, including ETFs with exposure to insurers like UnitedHealth and Elevance Health.

Via Benzinga

Topics ETFs

10 Worst Performing Large-Caps Last 12 Months ↗

February 14, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Which S&P500 stocks are the most active on Friday? ↗

February 14, 2025

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

Via Chartmill

Moderna (MRNA) Q4 2024 Earnings Call Transcript ↗

February 14, 2025

MRNA earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗

February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Via Benzinga

Topics Stocks

Discover which S&P500 stocks are making waves on Friday. ↗

February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 14, 2025

Via Benzinga

Moderna’s Q4 Losses Worse Than Feared, But Revenue Beat And Cost Cuts Boost Stock — Retail Sentiment Follows ↗

February 14, 2025

CEO Stéphane Bancel said the company remains focused on driving sales and achieving up to 10 product approvals by 2027, as well as removing nearly $1 billion in costs by the end of this year.

Via Stocktwits

Moderna's Q4 Loss Wider Than Expected ↗

February 14, 2025

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.

Via The Motley Fool

Which S&P500 stocks are moving before the opening bell on Friday? ↗

February 14, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 14, 2025

Via Benzinga

Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides ↗

February 14, 2025

Moderna reported a Q4 EPS loss of $2.91, missing estimates, with revenue down 66% YoY to $966 million. The company reaffirmed 2025 guidance and cost-cutting plans.

Via Benzinga

Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly

February 14, 2025

Biotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue...

Via StockStory

Topics Artificial Intelligence

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates

February 14, 2025

Via ACCESS Newswire

Dow Jumps Over 300 Points Following Recent Inflation Data; Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

February 14, 2025

Via Benzinga

Topics Economy Stocks

Palo Alto Networks, Moderna And 3 Stocks To Watch Heading Into Friday ↗

February 14, 2025

Via Benzinga

US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic' ↗

February 14, 2025

U.S. stock futures traded close to the flatline on Friday after Tuesday's rally. Futures of all four benchmark indices were slightly lower.

Via Benzinga

Topics Stocks

Earnings Scheduled For February 14, 2025 ↗

February 14, 2025

Via Benzinga

Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

February 14, 2025

Via Benzinga

Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch ↗

February 13, 2025

Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in the report:

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.